PLASMAPHERESIS, RITUXIMAB AND LOW-DOSE CYCLOPHOSPHAMIDE FOR REMISSION INDUCTION THERAPY IN SEVERE ANCA-ASSOCIATED VASCULITIS

被引：0
|
作者：
Gulati, Kavita [1 ]
McAdoo, Stephen [1 ]
Galliford, Jack [1 ]
Griffith, Megan [1 ]
Levy, Jeremy [1 ]
Cairns, Tom [1 ]
Pusey, Charles [1 ]
机构：
[1] Imperial Coll London, Renal & Vasc Inflammat Sect, London, England
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
FP159
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PLASMAPHERESIS, RITUXIMAB AND LOW-DOSE CYCLOPHOSPHAMIDE FOR REMISSION INDUCTION THERAPY IN SEVERE ANCA-ASSOCIATED VASCULITIS
    Gulati, Kavita
    Mcadoo, Stephen
    Tanna, Anisha
    Levy, Jeremy
    Griffith, Megan
    Cairns, Thomas
    Pusey, Charles
    RHEUMATOLOGY, 2019, 58
  • [2] Low-dose rituximab as induction therapy for ANCA-associated vasculitis
    Yukiko Takakuwa
    Hironari Hanaoka
    Tomofumi Kiyokawa
    Harunobu Iida
    Hisae Fujimoto
    Yoshioki Yamasaki
    Hidehiro Yamada
    Kimito Kawahata
    Clinical Rheumatology, 2019, 38 : 1217 - 1223
  • [3] Low-dose rituximab as induction therapy for ANCA-associated vasculitis
    Takakuwa, Yukiko
    Hanaoka, Hironari
    Kiyokawa, Tomofumi
    Iida, Harunobu
    Fujimoto, Hisae
    Yamasaki, Yoshioki
    Yamada, Hidehiro
    Kawahata, Kimito
    CLINICAL RHEUMATOLOGY, 2019, 38 (04) : 1217 - 1223
  • [4] LOW-DOSE RITUXIMAB AS INDUCTION THERAPY FOR JAPANESE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Takakuwa, Y.
    Hanaoka, H.
    Kiyokawa, T.
    Ishimori, K.
    Iida, H.
    Nagafuchi, H.
    Okazaki, T.
    Ozaki, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1260 - 1260
  • [5] Low-Dose Intravenous Methylprednisolone in Remission Induction Therapy for ANCA-Associated Vasculitis
    Floyd, Lauren
    Morris, Adam D.
    Shetty, Anamay
    Brady, Mark E.
    Ponnusamy, Arvind
    Warwicker, Paul
    Dhaygude, Ajay
    KIDNEY360, 2023, 4 (09): : 1286 - 1292
  • [6] Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis
    Mansfield, Nicholas
    Hamour, Sally
    Habib, Anne-Marie
    Tarzi, Ruth
    Levy, Jeremy
    Griffith, Megan
    Cairns, Tom
    Cook, H. Terence
    Pusey, Charles D.
    Salama, Alan D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (10) : 3280 - 3286
  • [7] Safety of remission induction with rituximab versus cyclophosphamide in patients 65 and older with severe ANCA-associated vasculitis
    Miloslavsky, E.
    Specks, U.
    Merkel, P.
    Seo, P.
    Spiera, R.
    Langford, C.
    Hoffman, G.
    Kallenberg, C.
    St Clair, W.
    Tchao, N.
    Ding, L.
    Ikle, D.
    Jepson, B.
    Brunetta, P.
    Stone, J.
    PRESSE MEDICALE, 2013, 42 (04): : 779 - 780
  • [8] LONG-TERM FOLLOW-UP OF A COMBINED RITUXIMAB AND LOW-DOSE CYCLOPHOSPHAMIDE REGIMEN FOR REMISSION INDUCTION IN RENAL ANCA-ASSOCIATED VASCULITIS
    McAdoo, Stephen Paul
    Gopaluni, Seerapani
    Medjeral-Thomas, Nicholas
    Tanna, Anisha
    Griffith, Megan
    Levy, Jeremy
    Cook, Terence
    Cairns, Thomas
    Salama, Alan
    Jayne, David
    Pusey, Charles
    RHEUMATOLOGY, 2017, 56 : 153 - 153
  • [9] Is Rituximab Superior to Cyclophosphamide for ANCA-Associated Vasculitis for Induction of Remission, and with a Better Safety Profile?
    Ignacio Garcia-Valladares
    Luis R. Espinoza
    Current Rheumatology Reports, 2010, 12 (6) : 395 - 398
  • [10] Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
    Cortazar, Frank B.
    Muhsin, Saif A.
    Pendergraft, William F., III
    Wallace, Zachary S.
    Dunbar, Colleen
    Laliberte, Karen
    Niles, John L.
    KIDNEY INTERNATIONAL REPORTS, 2018, 3 (02): : 394 - 402
12345